The association between statin use, genetic variation, and prostate cancer risk

By sjmartinez • April 8, 2025

Amiri A, Xu W, Zhang Q, Jeong JH, Freedland SJ, Fleshner NE, Finelli A, Hamilton RJ. The association between statin use, genetic variation, and prostate cancer risk. Prostate Cancer Prostatic Dis. 2025 Apr 7. doi: 10.1038/s41391-025-00964-x. Epub ahead of print. PMID: 40195554.

Tags: Hematology/Oncology, Publications

Trial design and end points in hepatocellular carcinoma: an EASL-AASLD-ILCA consensus statement

Llovet JM, Mauro E, Rimassa L, Mazzaferro V, Pinter M, Kelley RK, Chan SL, Kulik L, Pillai A, Roberts L, Sangro B, Casanovas T, Kaplan[...]

Severe autoimmunity after checkpoint inhibitor therapy in a patient with autoimmune polyglandular syndrome type 1

Lim A, Peluso EM, Downs IA, Horwich BH, Velez-Velez MA, Lechner MG. Severe autoimmunity after checkpoint inhibitor therapy in a patient with autoimmune polyglandular syndrome[...]

A phase 1 trial of HPV16 E7 T-cell receptor-engineered T cells in patients with relapsed/refractory HPV16-positive cancers (KITE-439 trial)

Kirtane K, Niu J, Blumenschein G, Massarelli E, Hanna GJ, Lee S, Bishop MR, Konecny GE, Mao D, Zheng Y, Rodriguez K, Kim JJ, Williams[...]